Export 287 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2021
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”, Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., “PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.”, PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
T. P. Lodise, Van Wart, S., Sund, Z. M., Bressler, A. M., Khan, A., Makley, A. T., Hamad, Y., Salata, R. A., Silveira, F. P., Sims, M. D., Kabchi, B. A., Saad, M. A., Brown, C., Oler, R. E., Fowler, V., and Wunderink, R. G., “Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).”, Antimicrob Agents Chemother, vol. 65, no. 3, 2021.
C. I. Campbell, Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., Bart, G., Schwartz, R. P., McNeely, J., Liebschutz, J. M., Tsui, J. I., Merrill, J. O., Glass, J. E., Lapham, G. T., Murphy, S. M., Weinstein, Z. M., Yarborough, B. Jo H., and Bradley, K. A., “PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.”, Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
2020
R. A. Schmidt, Zaki, A. Al, Desilet, N., Szefer, E., Ratnaweera, N., Peterson, E., and Y Y Lee, A., “Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.”, Thromb Res, vol. 188, pp. 106-114, 2020.
G. A. Abel, Hebert, D., Lee, C., Foran, J. M., Gore, S., Saber, W., Rollison, D., E, P., Wilson, S., Thompson, J., Waclawiw, M., DeFronzo, N. L., and Sekeres, M. A., “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in 62nd ASH Annual Meeting and Exposition, 2020.
T. Bach, Galbiati, S., Kennedy, J. K., Deye, G., Nomicos, E. Y. H., Codd, E. E., Garcia, H. H., Horton, J., Gilman, R. H., Gonzalez, A. E., Winokur, P., and An, G., “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open Label Phase 1 Multiple Ascending Dose and Food Effect Study.”, Antimicrob Agents Chemother, 2020.
E. J. Anderson, Lai, L., Wrammert, J., Kabbani, S., Xu, Y., Priyamvada, L., Hill, H., Goll, J. B., Jensen, T. L., Kao, C., Yildirim, I., Rouphael, N., Jackson, L., and Mulligan, M. J., “Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
S. Ge, Mendley, S. R., Gerhart, J. G., Melloni, C., Hornik, C. P., Sullivan, J. E., Atz, A., Delmore, P., Tremoulet, A., Harper, B., Payne, E., Lin, S., Erinjeri, J., Cohen-Wolkowiez, M., and Gonzalez, D., “Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents.”, Clin Transl Sci, 2020.
A. R. Maharaj, Wu, H., Zimmerman, K. O., Autmizguine, J., Kalra, R., Al-Uzri, A., Sherwin, C. M. T., Goldstein, S. L., Watt, K., Erinjeri, J., Payne, E. H., Cohen-Wolkowiez, M., and Hornik, C. P., “Population pharmacokinetics of olanzapine in children.”, Br J Clin Pharmacol, 2020.
C. E. H. Barber, Marshall, D. A., Szefer, E., Barnabe, C., Shiff, N. J., Bykerk, V., Homik, J., J Thorne, C., Ahluwalia, V., Benseler, S., Mosher, D., Twilt, M., and Lacaille, D., “A population-based approach to reporting system-level performance measures for rheumatoid arthritis care.”, Arthritis Care Res (Hoboken), 2020.
J. K. Legardy-Williams, Carter, R. J., Goldstein, S. T., Jarrett, O. D., Szefer, E., Fombah, A. E., Tinker, S. C., Samai, M., and Mahon, B. E., “Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.”, Emerg Infect Dis, vol. 26, no. 3, pp. 541-548, 2020.
K. E. Trocin, Weinstein, N. I., Oga, E. A., Mark, K. S., and Coleman-Cowger, V. H., “Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.”, J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
M. Sheikh, Collie, D., Edun, I., Feldman, R., Franklin, A., Gay, K., Johnson, R., Spector, I., Esterlitz, J., and M. Mendoza-Puccini, C., “Presentation Title - PUB: National Institute of Neurological Disorders and Stroke (NINDS) Common Data Element (CDE) Recommendations: Project Overview and Recent Updates.”. 2020.
L. Hu, Oden, N., Tai, B., and VanVeldhuisen, P., “Prevalence of obesity among U.S. population with substance dependence.”, Drug Alcohol Depend, vol. 217, p. 108293, 2020.
S. L. Mumford, Johnstone, E., Kim, K., Ahmad, M., Salmon, S., Summers, K., Chaney, K., Ryan, G., Hotaling, J. M., Purdue-Smithe, A. C., Chen, Z., and Clemons, T., “A Prospective Cohort Study to Evaluate the Impact of Diet, Exercise, and Lifestyle on Fertility (IDEAL): Design and Baseline Characteristics.”, Am J Epidemiol, 2020.
Y. - H. Chang, Duong, D. M., Goll, J. B., Wood, D. C., Jensen, T. L., Yin, L., Gelber, C. E., Seyfried, N. T., Anderson, E., Natrajan, M. S., Rouphael, N., Johnson, R. A., Sanz, P., Mulligan, M. J., and Hoft, D. F., “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
2019
T. Schonfeld and Rasmussen, L. M., “Partnering, Not Enduring: Citizen Science and Research Participation.”, Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
I. U. Scott, VanVeldhuisen, P. C., Barton, F., Oden, N. L., Ip, M. S., Blodi, B. A., Worrall, M., and Fish, G. E., “Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.”, JAMA Ophthalmol, 2019.
G. An, Murry, D. J., Gajurel, K., Bach, T., Deye, G., Stebounova, L. V., Codd, E. E., Horton, J., Gonzalez, A. E., Garcia, H. H., Ince, D., Hodgson-Zingman, D., Nomicos, E. Y. H., Conrad, T., Kennedy, J., Jones, W., Gilman, R. H., and Winokur, P., “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.”, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., “A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.”, Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
W. A. Keitel, Potter, G. E., Diemert, D., Bethony, J., Sahly, H. M. El, Kennedy, J. K., Patel, S. M., Plieskatt, J. L., Jones, W., Deye, G., Bottazzi, M. E., Hotez, P. J., and Atmar, R. L., “A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.”, Vaccine, vol. 37, no. 43, pp. 6500-6509, 2019.
S. L. Hillier, Ferrieri, P., Edwards, M. S., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H., and Baker, C. J., “A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.”, Clin Infect Dis, vol. 68, no. 12, pp. 2079-2086, 2019.
N. G. Rouphael, Hurwitz, S. J., Hart, M., Beck, A., Anderson, E. J., Deye, G., Osborn, B., Cai, S. Yi, Focht, C., Amegashie, C., Bowlin, T. L., Brooks, J., and Mulligan, M. J., “Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.”, Antimicrob Agents Chemother, vol. 63, no. 9, 2019.
M. E. Horwitz, Wease, S., Blackwell, B., Valcarcel, D., Frassoni, F., Boelens, J. Jan, Nierkens, S., Jagasia, M., Wagner, J. E., Kuball, J., Koh, L. Piu, Majhail, N. S., Stiff, P. J., Hanna, R., Hwang, W. Y. K., Kurtzberg, J., Cilloni, D., Freedman, L. S., Montesinos, P., and Sanz, G., “Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.”, J Clin Oncol, vol. 37, no. 5, pp. 367-374, 2019.